T ype 1 diabetes is associated with the development of vascular complications involving both the micro-and macrocirculation. Nephropathy, retinopathy, and atherosclerosis are frequently observed in patients with type 1 diabetes, and the progression of these conditions has a considerable impact on the prognosis of this disease (1) .
Vascular endothelium is a primary target of the unbalanced glycemic metabolism in type 1 diabetes. Evidence indicates that high glucose levels may alter the anti-atherogenic, anti-thrombotic properties of vascular endothelium, thus favoring the development of diabetic angiopathy (2) . On the other hand, inflammatory reactions taking place in the early phase of diabetes determine an increase in serum levels of a wide array of cytokines, including TNF-␣, interleukin-1␤ (IL-1␤), and interleukin-6 (IL-6), which may impair endothelial cell functions (3) .
The initial phase of vascular endothelium damage is defined by the term "endothelial perturbation," which refers to a reversible dysfunction of the endothelial cell. In vivo, endothelial perturbation is shown by a simultaneous increase in circulating vWF and tPA to levels 2 SD higher than the control values (4, 5) . Endothelial perturbation is associated with an ongoing prothrombotic state and an increased risk of thrombotic events (6) , and its persistence could represent a negative prognostic index.
Because the risk of developing vascular disease is not distributed homogeneously among patients with type 1 diabetes and the pathogenesis of vascular complications still is not completely defined, we examined the presence of endothelial perturbation in two populations of type 1 diabetic children and adolescents at different stages of the disease. We also investigated the possible relationship between inflammatory reaction and endothelial dysfunction. In this report, we show that endothelial perturbation represents an early and, in some cases, reversible event in children with type 1 diabetes.
RESEARCH DESIGN AND
METHODS -A total of 40 young patients with diabetes (18 girls and 22 boys, 12.5 Ϯ 4.6 years of age) attending the Diabetes Clinic at the Division of Pediatrics, University of Chieti, Italy, were examined several times between December 1996 and November 1998. All patients had type 1 diabetes, as defined in accordance with the criteria of the American Diabetes Association (7) . None of the children had clinical evidence of retinopathy, as assessed by routine ophthalmologic examinations and stereoscopic fundus photography, or nephropathy (absence of microalbuminuria or macroalbuminuria). Patients were subdivided into two groups according to the duration of diabetes (defined as time since first injection of insulin): Group A (n ϭ 20), duration of diabetes Ͻ1 year (4.2 Ϯ 3.8 months); and group B (n ϭ 20), duration of diabetes Ͼ1 year (58 Ϯ 35 months). All patients were being treated with insulin
). A total of 10 age-and sex-matched healthy children were also studied. Of the 20 children in group A, 16 were re-examined after 12 months. Informed consent was obtained from each subject (or from his/her parents) participating in the study. The protocol was approved by the local ethical committee. The baseline characteristics of patients and control subjects are detailed in Table 1 .
Venous blood samples were collected in tubes containing 3.8% sodium citrate. Plasma was prepared by centrifugation (2000g for 20 min), aliquoted, and stored at Ϫ20°C. vWF and tPA antigens were determined by enzyme-linked immunosorbent assay (ELISA) (American Diagnostica, Greenwich, CT). The intra-and interassay variation coefficients were 9 and 13% and 7 and 9%, respectively. Patients were considered to have endothelial perturbation when both vWF:Ag and tPA:Ag were more than 2 SD higher than the control mean value (4). Plasma F 1ϩ2 levels were measured using an ELISA kit (Behringwerke, Marburg, Germany). Intra-and interassay variation coefficients were 8 and 9%, respectively. TNF-␣ plasma levels were measured using an ELISA kit (R&D Systems Europe, Abingdon, Oxford, U.K.). Intra-and interassay coefficients of variation were Ͻ9%. Fasting plasma glucose levels were measured by the glucose oxidase method. HbA 1c was determined by automated highperformance liquid chromatography (8) . CRP was measured using a highly sensitive nephelometric assay (BN-II Nephelometer; Dade Behring, Milan, Italy). Conventional anti-islet cell antibodies (ICA-IgG) were detected by means of indirect immunofluorescence on cryostat sections of blood type O human pancreas (9) . Positive samples were then titered by dilutions in phosphate-buffered saline. End-point titers were converted to Juvenile Diabetes Foundation units. The threshold of detection was 5-10 Juvenile Diabetes Foundation units.
Statistical analyses were performed by 2 statistics or Fisher's exact test (if n Ͻ5) for independence and by appropriate Student's t test. Correlations were analyzed by the Spearman rank correlation test. Data are presented as the mean Ϯ SD and 95% CI. TNF-␣ values are expressed as median and range because they showed an appreciably skewed distribution. Only two-tailed probabilities were used for testing statistical significance (P Ͻ0.05). All calculations were made with the computer program Stat-View II (Abacus Concepts, Berkeley, CA).
RESULTS -Circulating levels of vWF:Ag were significantly higher in patients in group A compared with agematched healthy subjects or patients in group B (1,536 Ϯ 438 vs. 671 Ϯ 146 units/l, P ϭ 0.0001, and vs. 979 Ϯ 252 units/l, P ϭ 0.0008, respectively) (Fig.  1A) . Patients in group A also had increased plasma tPA:Ag levels in comparison with healthy subjects or patients in group B (11.2 Ϯ 4.4 vs. 5.3 Ϯ 1.3 ng/ml, P ϭ 0.0036, and vs. 7.4 Ϯ 3.0 ng/ml, P ϭ 0.0087, respectively) (Fig. 1B) . Of the 20 patients in group A, 14 (70%) had an increase in both vWF and tPA Ͼ2 SD higher than control values (endothelial perturbation). In contrast, only 20% of patients in group B had signs of endothelial perturbation.
Higher F 1ϩ2 levels compared with normal subjects or patients in group B (1.05 Ϯ 0.42 vs. 0.419 Ϯ 0.144 nmol/l, P ϭ 0.0016, and vs. 0.498 Ϯ 0.295 nmol/l, P ϭ 0.002, respectively) were found in patients in group A (Fig. 1C) . Direct correlations were found between F 1ϩ2 and either vWF ( ϭ 0.809, P ϭ 0.0001) or tPA levels ( ϭ 0.811, P ϭ 0.0001) (results not shown).
Patients in group A also had elevated circulating TNF-␣ levels compared with normal subjects or patients in group B (21. Data are n or (mean Ϯ SD). *Not determined.
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DIABETES CARE, VOLUME 24, NUMBER A total of 16 patients in group A were reviewed after 1 year. The results of the follow-up are summarized in Table 2 . Endothelial perturbation was still appreciable in 6 of the 11 patients in whom it was initially displayed, whereas in five cases, it was reversed. Interestingly, when patients were divided into groups according to changes in endothelial perturbation, their TNF-␣ levels showed significant differences. In fact, the patients who still had endothelial perturbation after 1 year were those who had the highest TNF-␣ levels at the beginning of the study, whereas patients in whom endothelial perturbation was reversed after 1 year were those who had significantly lower initial TNF-␣ levels. Patients who did not have endothelial perturbation from the beginning were those with the lowest initial TNF-␣ values (Fig. 3) . A similar pattern was observed with CRP (results not shown). In these patients, statistically significant correlations were observed between ICA and TNF-␣ ( ϭ 0.44, P ϭ 0.014), vWF ( ϭ 0.54, P ϭ 0.0025), tPA ( ϭ 0.45, P ϭ 0.0012), and F 1ϩ2 levels ( ϭ 0.56, P ϭ 0.0018) levels.
CONCLUSIONS -This study shows for the first time that the occurrence of endothelial perturbation represents an early and, in some cases, reversible event in the chronology of type 1 diabetes in children and adolescents. We observed that patients with duration of diabetes shorter than 1 year had a significant increase in both vWF and tPA levels and that endothelial perturbation was reversed in ϳ45% of these patients after 1 year (Fig. 1) . Therefore, it seems that signs of a vascular involvement can be appreciated as early as during the first decade of life of patients with diabetes. 
Endothelial perturbation in diabetic children
Considering the central role played by the endothelium in the regulation of vascular homeostasis (10), the question arises regarding the pathophysiological relevance of an early and, in most cases, transient endothelial perturbation in children and adolescents with diabetes. Should it be regarded as a transient epiphenomenon of the initial inflammatory autoimmune events taking place in diabetes? Or should it be considered an indicator of the risk for developing diabetic angiopathy in children and adolescents with type 1 diabetes? Long-term studies will hopefully answer this question. Consistent with previous observations (11), the present results also indicate that measurements of vWF and tPA may be useful to detect initial endothelium involvement in type 1 diabetes. In this regard, it must be noted that vWF is considered the best available noninvasive marker for endothelial dysfunction (12, 13) . Indeed, an elevation in vWF levels may be observed in diabetes (14) (in which it can precede the occurrence of microalbuminuria by ϳ3 years [2] ), as well as in hypertension (15), smoking (16), hypercholesterolemia (17) , and ischemic heart disease (18) . However, because vWF may also originate from platelets (19) , the combined determination of vWF and tPA, which is also secreted by endothelial cells (20) , may be a more specific and sensitive index of endothelial cell alteration. In our patients, endothelial perturbation was associated with an increment in F 1ϩ2 levels (Fig. 1) . This finding, previously unappreciated in children with diabetes, indicates that at the beginning of the disease, these patients may have a subclinical prothrombotic disorder. In fact, F 1ϩ2 generates thrombin and is formed when active tissue factor and activated coagulation factor X accumulate (21) . Increased F 1ϩ2 levels can be observed during coagulative disorders and are associated with a prothrombotic condition (4). Therefore, an increase in F 1ϩ2 levels is both a marker of an unbalanced tissue factor/tissue factor inhibitor pathway and an indicator of augmented thrombin generation. However, in approximately half of our children with type 1 diabetes, endothelial perturbation was a transient event; therefore, it would be difficult to draw a conclusion on the validity of endothelial perturbation and F 1ϩ2 determinations as predictive markers of diabetic angiopathy. However, it is striking that signs of endothelial perturbation and coagulative disorders can be already detected during childhood. Future studies will determine whether children showing persistent endothelial perturbation are at higher risk for developing vascular complications.
How is endothelial perturbation established in children with type 1 diabetes? Although previous studies have shown that poor glycemic control is related to the occurrence of vascular complications in juvenile diabetes (22, 23) , we were unable to observe a correlation between endothelial perturbation and HbA 1c levels. On the other hand, an inflammatory response is frequently observed in the initial phase of type 1 diabetes. Therefore, taking into account that among our patients, those with the shorter duration of disease had the higher incidence of endothelial perturbation, we hypothesized that a relationship might exist between the appearance of immune-inflammatory markers and the occurrence of endothelial perturbation. Indeed, we observed a strong increment in the levels of the inflammatory cytokine TNF-␣ and of the inflammation marker CRP, which correlated with the levels of endothelial perturbation indexes (Figs. 2  and 3 ). Moreover, ICA, which appeared at a very early stage in type 1 diabetes, positively correlated with TNF-␣ as well as with vWF, tPA, and F 1ϩ2 levels. Considered together, these findings seem to be consistent with the possibility that the early immune-inflammatory reaction may influence the appearance of endothelial perturbation in children with type 1 diabetes. These results are consistent with a recent observation showing a significant correlation between CRP and markers of endothelial dysfunction in patients with type 1 diabetes (24) and suggest that TNF-␣ may represent at least one of the agents that link the inflammatory reaction to the appearance of endothelial perturbation in children with type 1 diabetes. Indeed, TNF-␣ induces vWF release and transient and reversible endothelial dysfunction in humans (25, 26) . However, this does not exclude the possibility that some other factors may intervene in this process to determine whether endothelial perturbation becomes persistent. In this regard, the observation that patients in group A with the highest initial TNF-␣ levels (Fig. 3 ) corresponded to those with persistent endothelial perturbation after 1 year is intriguing. It might indicate that the degree of the initial inflammatory reaction could influence the chance of developing permanent endothelial dysfunction. However, due to the relatively small number of patients observed, this hypothesis must be investigated further.
In conclusion, in this study, we have shown that endothelial perturbation is an early event that correlates with the appearance of inflammatory markers in children and adolescents with type 1 diabetes. Although the persistence of endothelial perturbation could represent a potential index of the risk for developing vascular complications, the relationship between the occurrence of endothelial perturbation and the development of diabetic angiopathy in young patients still remains to be established by future prospective studies.
